Papers

2

Total Citations

14

H-Index

2

About

Hui Tian is a researcher whose work centers on surgical oncology and rare renal pathology, with a particular focus on advancing minimally invasive techniques for cancer treatment. Among Tian's most notable contributions is a comparative investigation of robotic-assisted minimally invasive esophagectomy (RAMIE) versus conventional minimally invasive esophagectomy (MIE) for thoracic esophageal cancer — a clinically significant area where robust evidence has historically been lacking. This work, which has garnered 9 citations since its 2024 publication, addresses a critical gap in understanding the potential advantages of robotic platforms in esophageal surgery, a procedure considered the gold standard for resectable esophageal cancer. Tian has also contributed to the characterization of rare renal tumors, including a case report on papillary renal neoplasm with reverse polarity (PRNRP), a recently defined entity distinguished by its unique histomorphological features, KRAS mutations, and indolent behavior. This 2023 publication has accumulated 5 citations, reflecting growing scholarly interest in this emerging diagnostic category. Together, Tian's research demonstrates a commitment to bridging surgical innovation with precise pathological characterization, offering meaningful guidance to clinicians navigating complex oncological cases.

Research Focus

Key Achievements

2
H-Index
2
Papers
14
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Robotic assisted minimally invasive esophagectomy versus minimally invasive esophagectomy
9 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Qilu Hospital of Shandong University, Dalian University of Technology

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago